Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irrelevant regions, and multimodal models that add clinical tables frequently rely on variables that were used to assign the diagnostic label in the first place. We study both issues with a deliberately lightweight slice-based encoder (ResNet18 with a one-layer Transformer over slices) on 1,075 baseline T1-weighted scans from ADNI-1. First, we use FastSurfer segmentations as an anatomical reference: YOLOv8 models trained on segmentation-derived labels localize Alzheimer-relevant structures with mAP_50 above 0.96, and a Grad-CAM comparison shows that the image-only classifier frequently attends to the skull, orbits and background. Second, we adapt a CLIP-style image - tabular contrastive framework and organize ADNIMERGE variables along a label-leakage spectrum. Fusion with cognitive scores yields 87.3% three-way accuracy, which we treat as a leakage-driven upper bound rather than an imaging result; fusion with regional volumes yields 73.0%. We observe that the choice of contrastive target changes what the image encoder learns: on MCI vs. CN, the image-only head reaches 52.4% when the encoder is aligned to cognitive scores and 73.8\% when aligned to volumes, although no tabular input is used at inference. Third, restricting the input to a per-subject crop of the medial temporal lobe raises image-only three-way accuracy from 58.7% to 65.1%. All results come from single runs on a small balanced test set, and we report confidence intervals and the protocol differences that prevent direct comparison with published numbers.
Early and accurate classification of Alzheimer's disease (AD) stages from magnetic resonance imaging (MRI) remains a critical challenge in clinical neuroimaging, particularly for distinguishing early-stage cognitive decline from normal aging. Existing deep learning approaches applied to publicly available augmented MRI...
Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities fo...
Yusuf Brima, M. Atemkeng, L. Namamula et al.· 0 citations
Deep learning for Alzheimer’s disease (AD) detection from structural magnetic resonance imaging (MRI) needs large, labelled datasets, yet many cohorts hold only a few hundred participants, for which conventional augmentation adds little anatomical diversity. In a two-stage pipeline, a variational autoencoder compressed...
Soheil Fallah, Nitsa J. Herzog· Journal of Imaging· 0 citations
Alzheimer’s disease (AD) classification from structural magnetic resonance imaging (MRI) may benefit from weak supervision that uses clinically meaningful but imperfect supervisory signals. We evaluated a weakly supervised framework in which a multilayer perceptron (MLP) trained on age, sex, and Mini-Mental State Exami...
Rong Xiao, T. Quan, Xing-Long Wu et al.· The Neuroscientist· 0 citations
Alzheimer's disease (AD) classification using magnetic resonance imaging (MRI) is essential for early clinical intervention. However, deep learning approaches often face challenges such as limited medical data, high intraclass variability, and uneven diagnostic contributions from individual MRI slices. To address these...
Deep learning models for Alzheimer disease (AD) classification routinely report near-perfect discrimination, yet few are shown to rest on AD-relevant neurobiology rather than on dataset artifacts, subject-level leakage, or non-brain image content. We present a fusion network combining T1 MRI and FDG PET across axial, c...
Known for his clear and elegant writing style, Bertsekas shaped fields from control and optimization to large-scale computation and artificial intelligence.